Cell Therapeutics Readies Commercial Launch of Pixuvri® in EU; Re-Alignment of Resources and Portfolio Priorities Reduces Burn Rate by more than 30%
21:35 EDT 19 Jun 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
SEATTLE, June 20, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ and MTA: CTIC), a company focused on translating science into novel cancer therapies, today announced that it is re-aligning its resources and re-prioritizing its product develo...
Other Sources for this Article
More From BioPortfolio on "Cell Therapeutics Readies Commercial Launch of Pixuvri® in EU; Re-Alignment of Resources and Portfolio Priorities Reduces Burn Rate by more than 30%"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
